The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Autumn heralds a worldwide corporate fight-back, led by telecoms sector
What a difference a month makes, if the M&A market is to be believed. After a dismal last week in August, when the value of worldwide deals dropped to its lowest value this year, the first week in September racked up a staggering $163bn (£103bn) worth. That figure leapfrogs the value of deals for the previous week – $20bn.
The cause of the September cheer? Communication. Not a surge in magic circle team-building but an explosion in telecoms deals, driving work to a few lucky firms. The number of deals conducted so far in September is actually slightly lower than the average for the previous month, but the total value rocketed to more than double the previous top-value week in 2013.
The beginning of the month saw Macfarlanes and Wachtell Lipton, Rosen & Katz take lead roles in advising Verizon Communications in its $130bn acquisition of a 45 per cent stake in Vodafone’s joint venture Verizon Wireless. Slaughter and May and Simpson Thacher & Bartlett also got a slice of the action in the US.
These deals were followed by GlaxoSmithKline’s (GSK) sale of drinks brands Lucozade and Ribena – a job nabbed by Allen & Overy (A&O) for GSK and Clifford Chance for Japanese buyer Suntory.
So what’s the rush? Some say the US Fed’s expected tightening of monetary policy and rising UK interest rates are pushing cautious investors to deal now while the going is good.
But not everyone agrees. A&O corporate partner Ed Barnett, who advised GSK, says the frisson is due to an increased appetite among private equity firms stirring from a summer slumber and producing a good climate for firms re-evaluating their assets.
“Confidence is coming back and companies are refocusing and looking at non-core assets,” he says.
Whatever the answer, M&A lawyers are cracking open the champers – or should that be the Japanese Ribena?